Thomas Malley

KNSA

Thomas Malley serves as Director at Kiniksa Pharmaceuticals, Ltd. (KNSA). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

1 trades

$575.0K

Total Sells

1 trades

$5.86M

Net Position

Net Seller

$5.28M

Companies Traded

KNSA, KURA

Active Period

Jun 2023 – Aug 2025

2 total trades

Most Recent

Sell KNSA

Aug 12, 2025 · $5.86M

Thomas Malley's Insider Trading at Kiniksa Pharmaceuticals, Ltd. (KNSA)

Buys

0 · $0.00

Sells

1 · $5.86M

Total Shares Bought

Total Shares Sold

177,769

KNSA Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Aug 12, 2025	Sell	177,769	$32.96	$5.86M	0

Thomas Malley's Insider Trading at Kura Oncology, Inc. (KURA)

Buys

1 · $575.0K

Sells

0 · $0.00

Total Shares Bought

50,000

Total Shares Sold

KURA Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Jun 21, 2023	Buy	50,000	$11.50	$575.0K	139,557

Related Insiders

Barry D Quart

Director

KNSASell · Feb 10, 2026

Mark Ragosa

CHIEF FINANCIAL OFFICER

KNSASell · Feb 9, 2026

DOYLE THOMAS JAMES

SVP, Finance & Accounting

KURASell · Jan 27, 2026

FORD KATHLEEN

officer: Chief Operating Officer

KURASell · Jan 27, 2026

Mollie Leoni

officer: Chief Medical Officer

KURASell · Jan 27, 2026

Brian T. Powl

officer: Chief Commercial Officer

KURASell · Jan 27, 2026

Teresa Brophy Bair

officer: Chief Legal Officer

KURASell · Jan 27, 2026

Francis Burrows

officer: Chief Scientific Officer

KURASell · Jan 27, 2026

Explore More Insider Trading Data

KNSA Insider Trading Activity

View all insider trades at Kiniksa Pharmaceuticals, Ltd.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity